Tower Research Capital »

Seelos Therapeutics Inc Class Equity shares owned by Tower Research Capital

Quarter-by-quarter ownership of Seelos Therapeutics Inc Class Equity shares owned by Tower Research Capital from 13F filings

Historical chart of Tower Research Capital investment in Seelos Therapeutics Inc Class Equity

Tip: Access up to 7 years of quarterly data

All positions including Seelos Therapeutics Inc Class Equity held by Tower Research Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Seelos Therapeutics Inc Class Equity by Tower Research Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $2.3k 3.9k 0.60

More positions owned by Tower Research Capital

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Broadcom (AVGO)
Tesla Motors (TSLA)
Advanced Micro Devices (AMD)
Costco Wholesale Corporation (COST)
Netflix (NFLX)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Adobe Systems Incorporated (ADBE)

View all positions for Tower Research Capital

Top funds holding Seelos Therapeutics Inc Class Equity

AdvisorShares Investments
Morgan Stanley
Geode Capital Management
BlackRock
Tower Research Capital
Jpmorgan Chase & Co
Bank of America Corporation
Group One Trading
Vermillion & White Wealth Management Group
Crewe Advisors
Wells Fargo & Company
Newbridge Financial Services Group
Westside Investment Management
National Bank Of Canada /fi/
Pnc Financial Services

View all funds holding Seelos Therapeutics Inc Class Equity